Scandinavian Simvastatin Survival Study (4S) The Lancet, Vol 344, November 19, 1994 Objectives • • Randomized trial of cholesterol lowering in 4,444 patients with CAD:…

Slide 1Current & Future Perspectives in the Treatment of Heart Failure Slide 2 Stewart et al. Eur J of Heart Failure 2001, 3(3):pp315-322. HF – More malignant than…

1. ScandinavianScandinavian Simvastatin SurvivalSimvastatin Survival Study (4S)Study (4S) The Lancet, Vol 344, November 19, 1994The Lancet, Vol 344, November 19, 1994 2.…

STABLE ISCHEMIC HEART DISEASE- HOW IS IT DIFFERENT FROM ACS..? DEV PAHLAJANI MD, FACC, FSCAI HOD Interventional Cardiology Breach Candy Hospital, Mumbai SIHD â VS â ACS…

Slide 1 Evidence Supporting Aggressive Glycemic Control Slide 2 Treatment of Type 2 Diabetes Slide 3 Sites of Action of Therapeutic Options for Type 2 Diabetes Slide 4 DCCT:…

Risk Factors for Coronary Artery Disease The Symphony of Life Yehuda Adler, M.D, MHA. Medical Diretor Shfela Region, Leumit Health Fund, Cardiac Rehabilitation, Chaim Sheba…

Risk Factors for Coronary Artery Disease The Symphony of Life Yehuda Adler, M.D, MHA. Medical Diretor Shfela Region, Leumit Health Fund, Cardiac Rehabilitation, Chaim Sheba…

The Prospective Pravastatin Pooling Project PPP Project Investigators Am J Cardiol 1995; 76:899–905 WOSCOPS Study Design Males aged 45–64 years with total-C  252 mg/dl…

HFSA 2010 Comprehensive Heart Failure Practice Guideline Key Recommendations Lindenfeld J, et al. HFSA 2010 Comprehensive Heart Failure Guideline. J Card Fail 2010;16:e1-e194.…

The evolving landscape of MS The evolving landscape of MS John Woolmore Consultant Neurologist UHB FIN14-C173. Date of preparation: September 2014 Plan Introduction Established…